1.
Sharma V, Chawla S, Garg S, Singh B. Efficacy and Safety of Vildagliptin and Remogliflozin as Add-On Therapy to Metformin in Patients of Type 2 Diabetes Mellitus: An open-label comparative study. Sultan Qaboos Univ Med J [Internet]. 2024Jan.29 [cited 2024May12];1(1). Available from: https://journals.squ.edu.om/index.php/squmj/article/view/6308